World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
30863
World Ranking
17385
National Ranking
8706

Research.com Recognitions

  • 2016 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Peter B. Bach is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Economics, Econometrics and Finance, with significant contributions in related subfields such as Economics and Econometrics, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Molecular Biology.

The scientist's recent papers reflect a focus on cancer diagnostics, drug trials, and healthcare economics. Notable publications include:

  • Cell-free DNA approaches for cancer early detection and interception (2023), published in the Journal for ImmunoTherapy of Cancer
  • Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs (2021), published in JAMA Network Open
  • Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs (2020), published in Reviews of Physiology, Biochemistry and Pharmacology
  • Mapping conflict of interests: scoping review (2021), published in BMJ
  • Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection (2024), published in Cancer Discovery

Their frequent co-authors include Victor E. Velculescu, Aaron Philip Mitchell, Niti U. Trivedi, Robert B. Scharpf, and Joachim Noldus, with multiple collaborations noted.

Peter B. Bach has contributed extensively to several scientific venues, with numerous publications appearing in the Journal of Clinical Oncology, Cancer Research, JAMA Network Open, Journal of the National Comprehensive Cancer Network, and The Oncologist.

The topics covered by their research include:

  • Health Systems, Economic Evaluations, Quality of Life
  • Economic and Financial Impacts of Cancer
  • Cancer Genomics and Diagnostics
  • Pharmaceutical Economics and Policy
  • Lung Cancer Diagnosis and Treatment
  • Pharmaceutical industry and healthcare
  • Kidney Stones and Urolithiasis Treatments

Among honors awarded to Peter B. Bach are membership in the National Academy of Medicine (NAM) appointed in 2016 and membership in the Association of American Physicians.

Best Publications

  • Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

    Joan L Warren;Carrie N Klabunde;Deborah Schrag;Peter B Bach

  • Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review

    Peter B. Bach;Joshua N. Mirkin;Thomas K. Oliver;Christopher G. Azzoli

  • Racial differences in the treatment of early-stage lung cancer.

    Peter B. Bach;Laura D. Cramer;Joan L. Warren;Colin B. Begg

  • Primary care physicians who treat blacks and whites.

    Peter B Bach;Hoangmai H Pham;Deborah Schrag;Ramsey C Tate

  • A paradigm shift in U.S. Breast reconstruction: increasing implant rates.

    Claudia R. Albornoz;Peter B. Bach;Babak J. Mehrara;Joseph J. Disa

  • Variations in Morbidity after Radical Prostatectomy

    Colin B. Begg;Elyn R. Riedel;Peter B. Bach;Michael W. Kattan

  • The Influence of Hospital Volume on Survival after Resection for Lung Cancer

    Peter B. Bach;Laura D. Cramer;Deborah Schrag;Robert J. Downey

  • Computed tomography screening and lung cancer outcomes.

    Peter B. Bach;James R. Jett;Ugo Pastorino;Melvyn S. Tockman

  • Variations in Lung Cancer Risk Among Smokers

    Peter B. Bach;Michael W. Kattan;Mark D. Thornquist;Mark G. Kris

  • Care Patterns in Medicare and Their Implications for Pay for Performance

    Hoangmai H. Pham;Deborah Schrag;Ann S. O'Malley;Beny Wu

  • Survival of blacks and whites after a cancer diagnosis.

    Peter B. Bach;Deborah Schrag;Otis W. Brawley;Aaron Galaznik

  • NCCN Task Force Report: Oral chemotherapy.

    Saul N. Weingart;Elizabeth Brown;Peter B. Bach;Kirby Eng

  • Influence of hospital procedure volume on outcomes following surgery for colon cancer.

    Deborah Schrag;Laura D. Cramer;Peter B. Bach;Alfred M. Cohen

  • Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

    Deborah Schrag;Laura D. Cramer;Peter B. Bach;Colin B. Begg

  • Pricing in the Market for Anticancer Drugs

    David H. Howard;Peter B. Bach;Ernst R. Berndt;Rena M. Conti

  • Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

    Frank C. Detterbeck;Peter J. Mazzone;David P. Naidich;Peter B. Bach

  • Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs

    Peter B. Bach

  • Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.

    Peter B. Bach;Cynthia Brown;Sarah E. Gelfand;Douglas C. McCrory

  • The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.

    Nabil P Rizk;Peter B Bach;Deborah Schrag;Manjit S Bains

  • Hospital and Surgeon Procedure Volume as Predictors of Outcome Following Rectal Cancer Resection

    Deborah Schrag;Katherine S. Panageas;Elyn Riedel;Laura D. Cramer

Frequent Co-Authors

Deborah Schrag
Deborah Schrag Harvard University
Colin B. Begg
Colin B. Begg Memorial Sloan Kettering Cancer Center
Katherine S. Panageas
Katherine S. Panageas Memorial Sloan Kettering Cancer Center
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
James R. Jett
James R. Jett Mayo Clinic
Kent A. Sepkowitz
Kent A. Sepkowitz Memorial Sloan Kettering Cancer Center
Andrew Briggs
Andrew Briggs University of Glasgow
David Howard
David Howard Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The evolving healthcare landscape in the USA has opened up various online education options for students aiming to enter or advance in medical careers. Pursuing an online degree can offer flexibility, affordability, and access to specialized fields outside of traditional medical school.

For those interested in healthcare administration, several cheapest mha programs online healthcare are available, providing essential management skills for leading hospitals and clinics. Similarly, registered nurses looking to reach the highest levels of clinical practice can explore the most affordable dnp programs to earn their Doctor of Nursing Practice online.

Students interested in the pharmaceutical field can now attend pharmacy school online, gaining the credentials for pharmacy licensure through flexible digital study. Likewise, digitization in healthcare has made careers in information management more vital, and a health information technology online degree can prepare graduates for these emerging roles.

These online programs broaden access to diverse healthcare career pathways, allow for study alongside work, and can significantly reduce overall education costs.

Best Scientists Citing Peter B. Bach

Trending Scientists